Watmind USA

Watmind USA is a healthcare biotechnology company specializing in rapid diagnostic testing devices for COVID-19 and influenza detection. The company's flagship product, SpeedySwab™ Rapid COVID-19 + Flu A&B Antigen Self-Test, is an FDA Emergency Use Authorized (EUA) point-of-care test designed for both at-home self-testing and professional healthcare settings. The test uses lateral flow assay (LFA) technology to detect SARS-CoV-2 variants, sub-variants, and influenza A and B viruses from anterior nasal swabs in approximately 15 minutes. Available in single-test, two-test, and four-test configurations, SpeedySwab™ is authorized for self-collected nasal swabs in individuals aged 14 and older, and adult-collected swabs for children aged 2 and older. The product has a 21-month shelf life and is distributed through major retailers and online channels. Watmind USA emphasizes accessibility, accuracy, and convenience in its product design and positioning. The company operates through exclusive distribution partnerships; Biolabs International LLC serves as the exclusive distributor based in San Diego, California. Watmind USA holds FDA EUA authorizations for both point-of-care (PoC) and over-the-counter (OTC) versions of SpeedySwab™, supporting widespread availability in pharmacies, grocery stores, and healthcare provider offices. The company serves families, travelers, healthcare systems, and public health agencies focused on rapid respiratory virus screening and outbreak detection.